Skip to content

PHARMACIE STIBBE: what changed

BE 0829.133.630NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€53,085
2024 · €97,809-€44,724
Equity
€197,594
2024 · €183,693+€13,901
Cash
€46,810
2024 · €69,408-€22,598
Balance sheet total
€360,528
2024 · €399,732-€39,204

Largest movements

2024 to 2025
Assets
  • Cash -€22,598

    down €22,598 (-32.6%), from €69,408 to €46,810

    mainly Contributions, distributions and other (-€39,184) and Other debts (-€26,177)

  • Stocks and contracts -€12,337

    down €12,337 (-7.1%), from €173,017 to €160,680

  • Tangible fixed assets -€4,990

    down €4,990 (-21.0%), from €23,811 to €18,821

    of which Other tangible fixed assets: -€4,272

Equity and liabilities
  • Other debts -€26,177

    down €26,177 (-99.9%), from €26,192 to €15

  • Tax, wage and social debts -€20,716

    down €20,716 (-40.0%), from €51,734 to €31,018

    of which Taxes: -€20,661

  • Profit (loss) carried forward +€13,901

    up €13,901 (+18.2%), from €76,408 to €90,309

  • Debts after one year -€7,645

    down €7,645 (-35.8%), from €21,355 to €13,710

Income statement
  • Gross operating margin -€49,440

    down €49,440 (-14.5%), from €341,757 to €292,317

  • Taxes -€15,971

    down €15,971 (-44.0%), from €36,295 to €20,324

  • Staff costs +€12,451

    up €12,451 (+6.6%), from €188,560 to €201,011

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €97,809
Gross operating margin -€49,440
Staff costs -€12,451
Depreciation -€70
Other operating charges -€210
Other operating items -€835
Financial income -€194
Financial charges +€2,505
Taxes +€15,971
Result 2025 €53,085
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€25,842
Investment €0
Financing -€48,440
Cash 2024 €69,408
Net result for the year +€53,085
Depreciation +€4,990
Stocks and contracts +€12,337
Receivables within one year -€2,259
Deferred charges and accrued income +€1,538
Trade debts +€15
Tax, wage and social debts -€20,716
Other debts -€26,177
Accrued charges and deferred income +€3,029
Debts after one year -€7,645
Current portion of long-term debt -€1,611
Contributions, distributions and other -€39,184
Cash 2025 €46,810
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €399,732 €360,528 -€39,204 -9.8%
Fixed assets 21/28 €35,111 €30,121 -€4,990 -14.2%
Tangible fixed assets 22/27 €23,811 €18,821 -€4,990 -21.0%
Furniture and vehicles 24 €1,799 €1,081 -€718 -39.9%
Other tangible fixed assets 26 €22,012 €17,740 -€4,272 -19.4%
Financial fixed assets 28 €11,300 €11,300 = 0.0%
Current assets 29/58 €364,621 €330,407 -€34,214 -9.4%
Stocks and contracts in progress 3 €173,017 €160,680 -€12,337 -7.1%
Stocks 30/36 €173,017 €160,680 -€12,337 -7.1%
Amounts receivable within one year 40/41 €119,188 €121,447 +€2,259 +1.9%
Trade receivables 40 €119,188 €100,771 -€18,417 -15.5%
Other amounts receivable 41 - €20,676 +€20,676
Cash at bank and in hand 54/58 €69,408 €46,810 -€22,598 -32.6%
Deferred charges and accrued income 490/1 €3,008 €1,470 -€1,538 -51.1%
Total equity and liabilities 10/49 €399,732 €360,528 -€39,204 -9.8%
Equity 10/15 €183,693 €197,594 +€13,901 +7.6%
Contributions 10/11 €42,000 €42,000 = 0.0%
Reserves 13 €65,285 €65,285 = 0.0%
Tax-exempt reserves 132 €65,285 €65,285 = 0.0%
Profit (loss) carried forward 14 €76,408 €90,309 +€13,901 +18.2%
Amounts payable 17/49 €216,039 €162,934 -€53,105 -24.6%
Amounts payable after more than one year 17 €21,355 €13,710 -€7,645 -35.8%
Financial debts 170/4 €21,355 €13,710 -€7,645 -35.8%
Amounts payable within one year 42/48 €141,468 €92,979 -€48,489 -34.3%
Current portion of amounts payable after more than one year 42 €11,056 €9,445 -€1,611 -14.6%
Trade debts 44 €52,486 €52,501 +€15 0.0%
Suppliers 440/4 €52,486 €52,501 +€15 0.0%
Taxes, remuneration and social security 45 €51,734 €31,018 -€20,716 -40.0%
Taxes 450/3 €23,617 €2,956 -€20,661 -87.5%
Remuneration and social security 454/9 €28,117 €28,062 -€55 -0.2%
Other amounts payable 47/48 €26,192 €15 -€26,177 -99.9%
Accrued charges and deferred income 492/3 €53,216 €56,245 +€3,029 +5.7%
Remuneration, social security and pensions 62 €188,560 €201,011 +€12,451 +6.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €4,920 €4,990 +€70 +1.4%
Other operating charges 640/8 €802 €1,012 +€210 +26.2%
Non-recurring operating charges 66A €3,660 €4,495 +€835 +22.8%
Gross operating margin 9900 €341,757 €292,317 -€49,440 -14.5%
Operating profit (loss) 9901 €143,815 €80,809 -€63,006 -43.8%
Financial income 75/76B €729 €535 -€194 -26.6%
Recurring financial income 75 €729 €535 -€194 -26.6%
Financial charges 65/66B €10,440 €7,935 -€2,505 -24.0%
Recurring financial charges 65 €10,440 €7,935 -€2,505 -24.0%
Profit (loss) for the period before taxes 9903 €134,104 €73,409 -€60,695 -45.3%
Income taxes 67/77 €36,295 €20,324 -€15,971 -44.0%
Profit (loss) for the period 9904 €97,809 €53,085 -€44,724 -45.7%
Profit (loss) for the period to be appropriated 9905 €97,809 €53,085 -€44,724 -45.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€343,408 to €441,252

Midpoint €384,176 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €197,594
Capitalised earnings €489,221 to €684,910
Indication €343,408 to €441,252

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€197,594
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€197,594

Capitalised earnings

net result for the year (9904)
2025
€53,085
excluding non-recurring income and charges
€57,580
2024
€97,809
excluding non-recurring income and charges
€101,469
2023
€43,035
excluding non-recurring income and charges
€46,423
2022
€35,279
excluding non-recurring income and charges
€39,101
2021
€16,361
excluding non-recurring income and charges
€20,205
Average result, excluding non-recurring income and charges
€68,491
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€489,221 / €570,758 / €684,910

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.